Abbott (ABT) Tops Q1 EPS by 2c; Boosts FY16 EPS Outlook
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/24/2026
- Nasdaq, S&P end lower as tech stocks fall
- Micron posts record profit as AI memory demand fuels explosive growth
- Brent settles at lowest since before start of Iran war as more tankers exit Hormuz
- All eyes on Micron earnings tonight as sell-off raises stakes for AI memory trade
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- Buildings collapse as quakes rock Venezuela, 'high casualties' likely
- Needham Starts NeoVolta (NEOV) at Buy
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- NextEra to discuss paying about $76 per share for Dominion, Bloomberg News reports
- Campbell Soup (CPB) Declares $0.39 Quarterly Dividend; 7.7% Yield
BTIG Believes Abbot (ABT) May be Renegotating Terms of Alere (ALR) Deal; Affirms at 'Buy'
April 20, 2016 2:27 PM EDTBTIG affirms Abbot Labs (NYSE: ABT) at Buy with a price target of $45 and comments on Alere (NYSE: ALR) chatter following commentary from Abbott CEO Miles White earlier.
Analyst Dane Leone said: Comments from CEO Miles... More
